A new study published by researchers at the University of Toronto indicates a very high level of resilience among Canadians with arthritis whose activities were restricted due to pain.
Bristol Myers shares IO combo data in colorectal cancer; Pfizer still waiting on Braftovi regimen survival figures
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS